KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biolife Solutions (BLFS) Net Margin (2016 - 2025)

Biolife Solutions (BLFS) has disclosed Net Margin for 16 consecutive years, with 40.11% as the latest value for Q4 2025.

  • On a quarterly basis, Net Margin fell 3941.0% to 40.11% in Q4 2025 year-over-year; TTM through Dec 2025 was 7.37%, a 2755.0% increase, with the full-year FY2025 number at 7.83%, up 2310.0% from a year prior.
  • Net Margin was 40.11% for Q4 2025 at Biolife Solutions, up from 1.87% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 119.21% in Q4 2022 to a low of 179.8% in Q2 2022.
  • A 5-year average of 9.03% and a median of 7.3% in 2021 define the central range for Net Margin.
  • Peak YoY movement for Net Margin: tumbled -20504bps in 2022, then soared 17726bps in 2023.
  • Biolife Solutions' Net Margin stood at 42.21% in 2021, then surged by 382bps to 119.21% in 2022, then dropped by -20bps to 95.75% in 2023, then dropped by -17bps to 79.52% in 2024, then tumbled by -50bps to 40.11% in 2025.
  • Per Business Quant, the three most recent readings for BLFS's Net Margin are 40.11% (Q4 2025), 1.87% (Q1 2025), and 79.52% (Q4 2024).